Education
About Us
Working with TipRanks
Follow Us
Neurocrine (NBIX)
NASDAQ:NBIX
Total Valuation
Neurocrine has a market cap or net worth of $12.32B. The enterprise value is ―.
Market Cap$12.32B
Enterprise Value―
Share Statistics
Neurocrine has 98,965,820 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding98,965,820
Owned by Insiders1.09%
Owned by Institutions26.26%
Financial Efficiency
Neurocrine’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 12.48%.
Return on Equity (ROE)0.13
Return on Assets (ROA)0.09
Return on Invested Capital (ROIC)12.48%
Return on Capital Employed (ROCE)0.18
Revenue Per Employee1.31M
Profits Per Employee189.61K
Employee Count1,800
Asset Turnover0.63
Inventory Turnover0.59
Valuation Ratios
The current PE Ratio of Neurocrine is 40.15. Neurocrine’s PEG ratio is -3.83.
PE Ratio40.15
PS Ratio0.00
PB Ratio4.78
Price to Fair Value5.29
Price to FCF24.45
Price to Operating Cash Flow22.88
PEG Ratio-3.83
Income Statement
In the last 12 months, Neurocrine had revenue of 2.36B and earned 341.30M in profits. Earnings per share was 3.40.
Revenue2.36B
Gross Profit2.32B
Operating Income570.50M
Pretax Income486.00M
Net Income341.30M
EBITDA639.70M
Earnings Per Share (EPS)3.40
Cash Flow
In the last 12 months, operating cash flow was 529.90M and capital expenditures -37.70M, giving a free cash flow of 492.20M billion.
Operating Cash Flow529.90M
Free Cash Flow492.20M
Free Cash Flow per Share4.97
Dividends & Yields
Neurocrine pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.65
52-Week Price Change-6.91%
50-Day Moving Average111.21
200-Day Moving Average122.11
Relative Strength Index (RSI)65.88
Average Volume (3m)1.41M
Important Dates
Neurocrine upcoming earnings date is Aug 5, 2025, TBA Not Confirmed.
Last Earnings DateMay 5, 2025
Next Earnings DateAug 5, 2025
Ex-Dividend Date―
Financial Position
Neurocrine as a current ratio of 3.40, with Debt / Equity ratio of 17.65%
Current Ratio3.40
Quick Ratio3.28
Debt to Market Cap0.00
Net Debt to EBITDA0.35
Interest Coverage Ratio4.51
Taxes
In the past 12 months, Neurocrine has paid 144.70M in taxes.
Income Tax144.70M
Effective Tax Rate0.30
Enterprise Valuation
Neurocrine EV to EBITDA ratio is 21.77, with an EV/FCF ratio of 24.99.
EV to Sales5.91
EV to EBITDA21.77
EV to Free Cash Flow24.99
EV to Operating Cash Flow23.39
Balance Sheet
Neurocrine has $943.50M in cash and marketable securities with $447.50M in debt, giving a net cash position of -$496.00M billion.
Cash & Marketable Securities$943.50M
Total Debt$447.50M
Net Cash-$496.00M
Net Cash Per Share-$5.01
Tangible Book Value Per Share$25.43
Margins
Gross margin is 98.25%, with operating margin of 24.22%, and net profit margin of 14.49%.
Gross Margin98.25%
Operating Margin24.22%
Pretax Margin20.63%
Net Profit Margin14.49%
EBITDA Margin27.16%
EBIT Margin26.01%
Analyst Forecast
The average price target for Neurocrine is $160.25, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$160.25
Price Target Upside27.80% Upside
Analyst ConsensusStrong Buy
Analyst Count21
Revenue Growth Forecast21.73%
EPS Growth Forecast-19.24%